FDA Adverse Event Injury Summary report: N

TANGORS POSTERIOR SYSTEM

MDR report key: 1890166 · Received October 29, 2010

Report

Report Number
9612420-2010-00003
Event Type
Injury
Date Received
October 29, 2010
Date of Event
August 25, 2010
Report Date
October 11, 2010
Manufacturer
ULRICH GMBH & CO. KG
Product Code
NKB
PMA / PMN Number
K052385
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AFTER VIEWING THE PRODUCTION ORDER AND MATERIAL CERTIFICATES OF AFFECTED IMPLANTS, NO DEVIATION WAS FOUND FROM THE SPECIFICATIONS. THE EXPLANTS SHOWED A VIOLENT RUPTURE IN THE PERFORATION HOLES AND BELOW THE SCREW HEAD. MICROSCOPIC EXAMINATION AND MEASUREMENT OF THE EXPLANTS WAS NOT POSSIBLE, AS THESE ARE RETAINED BY THE HOSPITAL. ACCORDING TO INFORMATION PROVIDED BY THE ATTENDING DOCTORS OF THE CLINIC, IT WAS REPORTED ON THE CASE OF A (B)(6) FEMALE PATIENT ((B)(6)), WHICH WAS IN CLINICS IN (B)(6) 2010 DUE TO A DEGENERATIVE SPONDYLOLISTHESIS L5/S1 AND OTHER CHANGES, SHE WAS STABILIZED FROM L3 TO S1 FOR THE FIRST TIME. A SCREW BREAKAGE IN S1 IN (B)(6) 2010 REQUIRED A FIRST REVISION SURGERY. RE-SCREW BREAKAGE IN BOTH SIDES S1 IN (B)(6) 2010 FORCED FURTHER REVISION. DIAGNOSIS AND SURGICAL TREATMENT WERE JUST REGULAR, ACCORDING TO THE TREATING PHYSICIANS. THE PATIENT HAS NOW BEEN SUPPLIED WITH A BRACE AFTER SURGERY AND PRESCRIBED AN INCREASED PHYSICAL PROTECTION. THE IMPLANT FAILURE WAS DESCRIBED AS AN UNFORTUNATE CONSEQUENCE OF AN UNEXPLAINED CONSTELLATION AT (B)(6) AND SEVERELY REDUCED BONE MASS. THE INVESTIGATION OF THE IMPLANTS SHOWED NO DEVIATIONS FROM THE SPECIFICATIONS. IMPLANT FAILURE CANNOT BE ENTIRELY EXCLUDED. OUR INSTRUCTION FOR USE POINTS OUT THE POSSIBILITY OF IMPLANT FAILURE AS A POSTOPERATIVE COMPLICATION.

Description of Event or Problem · 1

PEDICLE SCREW BREAKAGE AT S1 BOTH SIDES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TANGORS POSTERIOR SYSTEM NKB (MNH,MNI) NKB ULRICH GMBH & CO. KG WS14703921/14707167

Patients

Seq Age Sex Outcome Treatment
1 45 YR Required Intervention